Company Quantum Genomics Deutsche Boerse AG
Equities
2QG
FR0011648971
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.1222 EUR | +8.14% | +6.26% | +38.86% |
Business Summary
All sales are abroad.
Number of employees: 3
Sales per Business
EUR in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Innovative Medicines
100.0
%
| 1 | 100.0 % | 0 | 100.0 % | -98.34% |
Sales per region
EUR in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
France
100.0
%
| 1 | 100.0 % | 0 | 100.0 % | -98.34% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 63 | - | |
Lionel Ségard
FOU | Founder | 56 | 23/05/23 |
Benoît Gueugnon
DFI | Director of Finance/CFO | - | 01/18/01 |
Bruno Besse
CTO | Chief Tech/Sci/R&D Officer | - | 01/17/01 |
Chief Tech/Sci/R&D Officer | - | - | |
General Counsel | - | 04/22/04 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Lionel Ségard
FOU | Founder | 56 | 23/05/23 |
François Pelen
BRD | Director/Board Member | 67 | - |
Chief Executive Officer | 63 | - | |
Director/Board Member | 58 | - | |
François Durvye
BRD | Director/Board Member | - | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 34,854,981 | 30,403,091 ( 87.23 %) | 0 | 87.23 % |
Company contact information
Sector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+23.37% | 47.02B | |
+48.83% | 41.86B | |
-0.94% | 41.76B | |
-5.86% | 28.8B | |
+11.29% | 26.05B | |
-20.92% | 19.15B | |
+3.20% | 12.55B | |
-2.67% | 11.82B | |
+30.23% | 12.34B |
- Stock Market
- Equities
- ALQGC Stock
- 2QG Stock
- Company Quantum Genomics